EUVIMEDEUVIMED entdecken
LeserbriefKommentarOpen Access · CC BY 4.0

Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”

Netchanok Sae-Sim, Norasate Samarnthai, Warapan Numprasit iD

Current Oncology · 27.04.2026 · 33 (5) · 248

DOI: 10.3390/curroncol33050248 ↗

Kurz gefasst

Leserbrief in der Zeitschrift Current Oncology, online erschienen am 27.04.2026. Verfasst von Netchanok Sae-Sim und 2 weiteren Autor:innen. Beteiligte Einrichtung: Division of Head Neck and Breast Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand. Hauptthemen laut MEDLINE: Breast Neoplasms, Mastectomy, Tamoxifen, Neoplasm Recurrence, Local. Die Arbeit nennt 2 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Siriraj Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

We thank Venkataraman and Mokbel [...]

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Breast NeoplasmsMastectomyTamoxifenNeoplasm Recurrence, LocalCarcinoma, Intraductal, NoninfiltratingAntineoplastic Agents, HormonalHumansFemaleDisease-Free Survival

Substanzen

TamoxifenAntineoplastic Agents, Hormonal

Autor:innen und Institutionen

  • Division of Head Neck and Breast Surgery, Department of Surgery, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.
  • Department of Pathology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand.

ORCID-Profile: Warapan Numprasit

Förderung

  • Siriraj Foundation

Zitieren

APA

Sae-Sim, N., Samarnthai, N., & Numprasit, W. (2026). Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”. Current Oncology, 33(5), 248. https://doi.org/10.3390/curroncol33050248

Vancouver

Sae-Sim N, Samarnthai N, Numprasit W. Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”. Current Oncology. 2026;33(5):248. doi:10.3390/curroncol33050248

BibTeX
@article{SaeSim2026,
  author = {Sae-Sim, Netchanok and Samarnthai, Norasate and Numprasit, Warapan},
  title = {Reply to Venkataraman, J.; Mokbel, K. Reconsidering the Interpretation of “Recurrence-Free Survival” After Mastectomy for DCIS. Comment on “Sae-sim et al. Tamoxifen Reduces Breast Cancer Recurrence in Women with DCIS Who Underwent Mastectomy. Curr. Oncol. 2026, 33, 89”},
  journal = {Current Oncology},
  year = {2026},
  volume = {33},
  number = {5},
  pages = {248},
  doi = {10.3390/curroncol33050248}
}
Kostenlos starten →